[Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination].
METHODS
Miller Fisher Syndrome (MFS) is the most frequent variant of the Guillain-Barré Syndrome. It is characterised by the classic triad of ophthalmoplegia, ataxia and areflexia. We present a case of a patient who developed these clinical findings 5 days after flu vaccination.


CONCLUSIONS
Miller Fisher Syndrome is an unusual condition seen in ophthalmologic clinical practice. Although respiratory and digestive infections have been reported as antecedent infectious agents in MFS, it has not previously been described in relation to the flu vaccine.
Blanco-Marchite
C I
CI
Servicio de Oftalmología, Complejo Hospitalario Universitario de Albacete SESCAM, Albacete, España. cblancomar@yahoo.es
Buznego-Suárez
L
L
Fagúndez-Vargas
M A
MA
Méndez-Llatas
M
M
Pozo-Martos
P
P
D000918:Antibody Specificity; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D004172:Diplopia / Q000209:etiology; D005158:Facial Paralysis / Q000209:etiology; D020233:Gait Disorders, Neurologic / Q000209:etiology; D005732:Gangliosides / Q000276:immunology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007252:Influenza Vaccines / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D019846:Miller Fisher Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D009325:Nausea / Q000209:etiology; D009886:Ophthalmoplegia / Q000209:etiology*; D012120:Respiration Disorders / Q000209:etiology
D001323:Autoantibodies; D001324:Autoantigens; D005732:Gangliosides; D016756:Immunoglobulins, Intravenous; D007252:Influenza Vaccines; C039129:GQ1b ganglioside